Frontlight ResearchEarly access
Trial site
MVZ fuer Haematologie und Onkologie Ravensburg GmbH
- 18running trials
- 2closed trials
The trials here
What the 20 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer5 trials
- Chronic lymphocytic leukaemia3 trials
- Colorectal cancer3 trials
- Lung cancer2 trials
- Ovarian cancer2 trials
- Triple-negative breast cancer2 trials
- Endometrial cancer1 trial
- Follicular lymphoma1 trial
- Gastric and oesophageal cancer1 trial
- Liver and biliary tract cancer1 trial
- Phase
- Phase 314 trials
- Phase 26 trials
- Status
- Recruiting10 trials
- Active, not recruiting6 trials
- Completed2 trials
- Not yet recruiting2 trials
- Lead sponsor
- German CLL Study Group2 trials
- Tesaro, Inc.2 trials
- Astellas Pharma Global Development, Inc.1 trial
- BeOne Medicines I GmbH1 trial
- BioNTech SE1 trial
- and 13 more
Running trials
Recruiting
Recruiting
A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO)
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Metastatic breast cancer4 recruiting
- Colorectal cancer2 recruiting
- Triple-negative breast cancer2 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Lung cancer1 recruiting
- Ovarian cancer1 recruiting
Closed trials
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 19 Nov 2026